Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Taiwan - Delayed Quote TWD

Wellell Inc. (4106.TW)

Compare
24.90
+0.50
+(2.05%)
At close: April 2 at 1:30:32 PM GMT+8
Loading Chart for 4106.TW
  • Previous Close 24.40
  • Open 24.45
  • Bid 24.55 x --
  • Ask 24.90 x --
  • Day's Range 24.35 - 24.90
  • 52 Week Range 23.90 - 29.30
  • Volume 47,993
  • Avg. Volume 173,180
  • Market Cap (intraday) 2.513B
  • Beta (5Y Monthly) 0.37
  • PE Ratio (TTM) 21.84
  • EPS (TTM) 1.14
  • Earnings Date --
  • Forward Dividend & Yield 0.80 (3.21%)
  • Ex-Dividend Date Jul 31, 2024
  • 1y Target Est --

Wellell Inc. provides medical solutions for healthcare professionals worldwide. The company offers wound management products, including Serene Air and Serene Elite, which are alternating pressure redistribution systems for patients with high to very high risk for pressure ulcers; ACS Turn, a low air lateral turning mattress; Pro-care Optima, an alternating pressure redistribution system for patients with high to very high risk of pressure injuries; Pro-care turn, a bilateral turning air mattress for patients with medium to high risk of pressure injuries; Domus Auto, Domus 4, and Verso for patients with medium to high risk of pressure injury; Domus 3 for patients with medium risk of pressure injury; Domus 2s for patients with low to medium risk of pressure injury; Domus 1 for patients in low risk of pressure injury; Sedens 500 and Sedens 400, which are seat cushions; and Flexi-Air, a non-powered hybrid mattress. It also provides respiratory therapy products, such as nasal masks, full face masks, nasal pillows mask, portable suction unit, and compressor nebulizers; iCH Auto and XT Auto for automatic positive airway pressure; XT Prime, XT Sense, and XT Fit for continuous positive airway pressure; XT Heated Humidifier for humidification; and medical equipment. The company was founded in 1990 and is based in New Taipei City, Taiwan.

www.wellell.com/en

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 4106.TW

View More

Performance Overview: 4106.TW

Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

4106.TW
0.00%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
7.54%

1-Year Return

4106.TW
10.84%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
4.06%

3-Year Return

4106.TW
0.99%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
20.84%

5-Year Return

4106.TW
11.29%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
120.40%

Compare To: 4106.TW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4106.TW

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    2.51B

  • Enterprise Value

    2.02B

  • Trailing P/E

    21.84

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.05

  • Price/Book (mrq)

    1.04

  • Enterprise Value/Revenue

    0.85

  • Enterprise Value/EBITDA

    7.90

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.83%

  • Return on Assets (ttm)

    2.59%

  • Return on Equity (ttm)

    4.85%

  • Revenue (ttm)

    2.39B

  • Net Income Avi to Common (ttm)

    115.24M

  • Diluted EPS (ttm)

    1.14

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    782.77M

  • Total Debt/Equity (mrq)

    12.72%

  • Levered Free Cash Flow (ttm)

    132.17M

Research Analysis: 4106.TW

View More

Company Insights: 4106.TW

Research Reports: 4106.TW

View More

People Also Watch